Beneficial effects of SGLT2 inhibitor on metabolic inflexibility and visceral fat amount in animal model of obese type 2 diabetes

BACKGROUND: Obesity and type 2 diabetes mellitus (T2DM) are often accompanied with a disrupted diurnal rhythm of eating and sustained anabolic state, leading to metabolic inflexibility. In the present study, we plan to investigate effects of a sodium glucose co-transporter 2 (SGLT2) inhibitor, canag...

Descripción completa

Detalles Bibliográficos
Autores principales: Hara, Kento, Sakai, Yusuke, Tajiri, Yuji, Nomura, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587290/
https://www.ncbi.nlm.nih.gov/pubmed/36281369
http://dx.doi.org/10.1016/j.heliyon.2022.e11012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587290/
https://www.ncbi.nlm.nih.gov/pubmed/36281369
http://dx.doi.org/10.1016/j.heliyon.2022.e11012

Ejemplares similares